cola lipid c efficacy against albicans Candida accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2α signaling Frontiers | Pore-forming peptide C14R
Frontiers Pore forming peptide C14R exhibits potent antifungal activity against clinical isolates of Candida albicans and Candida auris Antifungal Efficacy of Antimicrobial Peptide Octominin II against Candida albicans The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports CO2 enhances the formation, nutrient scavenging and drug resistance properties of C. albicans biofilms npj Biofilms and Microbiomes
Pay in 4 interest-free payments of $7.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



